Fundamental Analysis
59 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +90.0% | +84.3% | 2 / 3 | +185.8% | -6.05 pp | +20.61 pp | +12.5% | 2.42 | 5.20 | 211 | +185,8% | −1,6 | +89,7% | 5.20 | 19.24 | −73,0% |
| Pts | 12 | 12 | 8 | 12 | 0 | 12 | 0 | -4 | 12 | |||||||
Valuation annotation:Price: 7.400 (close price on 2026-10-19)EPS (TTM): 1.423
Financial charts
1.Revenue & growth
VND bn211Q2/26
1.Revenue & growth
VND bn211Q2/26
2.Profit & growth
VND bn-1,57Q2/26
3.Profit mix (Penman)
VND bn30,3Q2/26
4.Margins & cost structure
%16.1%Q2/26
5.Returns & cash cycle
% · days8.7%Q2/26
6.Earnings quality & cash
VND bn-104Q2/26
7.Asset structure
VND bn700Q2/26
8.Funding & debt health
VND bn · times700Q2/26
9.Revenue backlog
VND bn74,5Q2/26
10.Valuation
times · %4,0×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %-113Q2/26
Adjusted EPS growth, latest quarter
No comparable quarter a year earlier
Average adjusted EPS growth, 3 quarters
657%
averaged over 2 quarter(s)
Quarters at 25%+ growth
1/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26